MOO news

VanEck Agribusiness · Agriculture & Food Innovation

Stories about this fund's companies, ranked by fund weight and recency. Times are local.

The Manila times · 28 Oct 2026, 13:18 UTC
Webinar to Explore How Gas and Diesel Engines Have Powered America's Past and What Lies Ahead
8.9% of MOO
Investing.com · 28 Oct 2026, 06:00 UTC
Earnings call transcript: Piramal Pharma Q2 2026 shares jump 14% on raised outlook By Investing.com
9.3% of MOO
The Manila times · 27 Oct 2026, 16:58 UTC
Menopause and Heart Health: Expert Explains What Every Woman Should Know with YourUpdateTV
9.3% of MOO
International Business Times, Singapore Edition · 28 Oct 2026, 07:35 UTC
Keval Barvaliya's IEEE Keynote Puts a Hardware Problem at the Centre of the AI Trust Debate
4.3% of MOO
Where to buy MOO
- [Broker A]Visit ↗
- [Broker B]Visit ↗
[Affiliate and risk wording from the law firm]
China Daily · 27 Oct 2026, 00:00 UTC
Bayer banks on new market opportunities in China
9.3% of MOO
wallstreet:online · 26 Oct 2026, 20:00 UTC
Bayer Shares New Post Hoc Analysis Of Self-Reported Sleep-Related Outcomes with Lynkuet (elinzanetant) in Women with Moderate to Severe Vasomotor Symptoms at the Menopause Society Annual Meeting
9.3% of MOO
Where to buy MOO
- [Broker A]Visit ↗
- [Broker B]Visit ↗
[Affiliate and risk wording from the law firm]
RTTNews · 26 Oct 2026, 15:08 UTC
Bayer's Asundexian Becomes First Factor XIa Inhibitor Approved In China For Stroke Prevention
9.3% of MOO
Morningstar · 26 Oct 2026, 11:59 UTC
Bayer Gets China Approval for Stroke-Prevention Drug in Global First for New Class -- Update
9.3% of MOO
Markets Insider · 27 Oct 2026, 01:37 UTC
New Sell Rating for Nutrien (NTR), the Basic Materials Giant
6.2% of MOO
Market Screener · 26 Oct 2026, 10:19 UTC
Bayer Reports Positive Clinical Data for Darolutamide
9.3% of MOO
Reuters · 26 Oct 2026, 10:08 UTC
China approves Bayer blood thinner asundexian
9.3% of MOO
Investing.com · 26 Oct 2026, 10:05 UTC
Stock Market News - Investing.com
9.3% of MOO
Bloomberg Business · 26 Oct 2026, 09:21 UTC
Bayer Wins China Approval for Potential Blockbuster Stroke Drug
9.3% of MOO
Market Screener · 26 Oct 2026, 09:20 UTC
Bayer at Top of DAX, Nubeqa Data and Asundexian Approval
9.3% of MOO
Morningstar · 26 Oct 2026, 08:58 UTC
Bayer Gets in China Its First Global Approval for Stroke Prevention Drug
9.3% of MOO
Market Screener · 26 Oct 2026, 08:37 UTC
Bayer's Xarelto successor Asundexian approved in China
9.3% of MOO
Investing.com · 28 Oct 2026, 14:44 UTC
AGCO earnings up next as farm equipment maker faces demand test By Investing.com
1.9% of MOO
China Daily · 26 Oct 2026, 00:00 UTC
MNCs tap China for global scale
9.3% of MOO
Markets Insider · 25 Oct 2026, 20:50 UTC
Bayer announces new data at ESMO 2026 on NUBEQA
9.3% of MOO
Nikkei Asia · 27 Oct 2026, 22:11 UTC
With China having fewer kids, dairies rethink milk for adults
1.9% of MOO

MOO news

Where to buy MOO

Where to buy MOO